Back to Search
SUSAN STINSON, M.D.
M.D.
Radiation Oncology Physician
NPI: 1578656625Individual
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
D0034840(MD)
Research & Publications (20)
Plasma pharmacokinetics of a liver-selective nitric oxide-donating diazeniumdiolate in the male C57BL/6 mouse.
PMID 12028666·Xenobiotica·2002
7-preclinical
Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
PMID 19577867·Int J Radiat Oncol Biol Phys·2010
8-other
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.
PMID 19381019·J Clin Invest·2009
7-preclinical
Optimization of naphthalimide-imidazoacridone with potent antitumor activity leading to clinical candidate (HKH40A, RTA 502).
PMID 17939651·J Med Chem·2007
7-preclinical
Design, synthesis, and evaluation of in vivo potency and selectivity of epoxysuccinyl-based inhibitors of papain-family cysteine proteases.
PMID 17524981·Chem Biol·2007
7-preclinical
Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells.
PMID 16331501·Cancer Chemother Pharmacol·2006
8-other
Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl.
PMID 16331493·Cancer Chemother Pharmacol·2006
4-observational
Synthesis, structure-activity relationship, and p210(bcr-abl) protein tyrosine kinase activity of novel AG 957 analogs.
PMID 15698792·Bioorg Med Chem·2005
8-other
The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappaB activity in drug-sensitive MCF-7 cells.
PMID 15655410·Anticancer Drugs·2005
8-other
Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells.
PMID 15355884·Drug Metab Dispos·2004
8-other
17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models.
PMID 15057143·Anticancer Drugs·2004
7-preclinical
SarCNU, a nitrosourea analog on a day 1, 5, and 9 oral schedule: a phase I and pharmacokinetic study in patients with advanced solid tumors.
PMID 12525514·J Clin Oncol·2003
3-trial
Clinical pharmacology of flavopiridol following a 72-hour continuous infusion.
PMID 14519054·Ann Pharmacother·2003
3-trial
Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles.
PMID 12467219·Mol Cancer Ther·2002
7-preclinical
Excellence in forensic practice: a clinical ladder model for recruiting and retaining sexual assault nurse examiners (SANEs).
PMID 11960135·J Emerg Nurs·2002
8-other
Identification of the major metabolite of 2,5-bis(5-hydroxymethyl-2-thienyl)furan (NSC 652287), an antitumor agent, in the S9 subcellular fraction of dog liver cells.
PMID 11863292·J Chromatogr B Analyt Technol Biomed Life Sci·2002
7-preclinical
Prosthetic valve endocarditis due to vancomycin-resistant Enterococcus faecium: treatment with chloramphenicol plus minocycline.
PMID 12015709·Clin Infect Dis·2002
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6420 ROCKLEDGE DR, SUITE 1200
BETHESDA, MD 20817 - Phone
- (301) 896-6331
Quick Facts
- NPI
- 1578656625
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile